P360 Builds Out New Artificial Intelligence-Powered Platform
EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.
P360, a software company that specializes in business technology development and implementation for pharmaceutical and life sciences companies, has introduced EdenHelp. This generative artificial intelligence (AI)-powered information platform allows pharmaceutical, medical device, and other life sciences companies to be able to instantly share responses and product information with healthcare professionals (HCPs) and patients in real-time.
During a time in which one must be conscientious of protecting patient data, the platform has been built on a private large language model (LLM), helping to keep that both confidential and secure.
“We are excited to introduce EdenHelp, our intuitive new platform for life sciences companies that want to seamlessly share information about prescription drugs or medical devices with healthcare professionals and patients,” says Anupam Nandwana, P360’s CEO and co-founder. “By streamlining access to vital details about products and their use, companies are taking a giant leap forward in improving their customer experience.”
Another advantage of the platform, the provider notes, is its flexibility. The platform can integrate with various workflows, including medical information requests (MIR), sample requests, signature capture, and scheduling. As a result, HCPs and patients will be able to more effortlessly communicate with these life sciences companies, offering a more streamlined experience that can increase customer satisfaction and save time.
Reference
P360 Automates the Sharing of Information About Life Sciences Products with EdenHelp. P360. News release. January 16, 2024. Accessed January 18, 2024. https://www.p360.com/newsroom/p360-edenhelp-life-sciences-information/?utm_content=278661267&utm_medium=social&utm_source=twitter&hss_channel=tw-3024361036%2F
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.
